from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2883c/pyrH

LFCtreatmentdescriptionclass of inhibitor

-0.819

Amikacinug/mL Amikacintranslation

-1.116

Cap5-10ug/mL Capreomycintranslation

-1.619

Rox10-50 ug/mL Roxithromycintranslation

0.074

SM2-5 ug/mL Streptomycintranslation

-1.068

Tet5-10 ug/mL Tetracyclinetranslation

0.046

Rif0.2-5ug/mL Rifampicintranscription

-0.322

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.200

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.910

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.081

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.284

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.040

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.528

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.492

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.362

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.600

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.074

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.261

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.156

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.106

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.170

KCN5-20 ug/mL Potassium cyaniderespiration

0.530

NaN30.2-2 mM Sodium aziderespiration

0.233

Nigericin50 uM Nigericinrespiration

-0.499

TRC10-150 ug/mL Triclosanrespiration

-1.974

TRZ10-25 ug/mL Thioridazinerespiration

-0.516

Valinomycin0.5-10 uM Valinomycinrespiration

0.197

ZnSO42 mM ZnSO4respiration

0.124

menadione6-10 ug/mL Menadionerespiration

-0.318

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.252

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.697

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.032

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.439

NRP_1Non-replicating persistence stage 1dosRassociated

0.401

Amp0.2mg/mL AmpicillincellWall

0.177

Cephalexin20-100 ug/mL CephalexincellWall

0.130

Cerulenin0.32-5 ug/mL CerulenincellWall

0.257

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.121

EMB10-20 ug/mL EthambutolcellWall

0.778

Eta12-40 ug/mL EthionamidecellWall

1.006

INH0.2-0.4 ug/mL IsoniazidcellWall

0.692

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.625

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.130

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.044

BZA0.12 mg/mL BenzamidearomaticAmides

1.047

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.857

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.077

H2O24 mM hydrogen peroxideDNAdamaging

-0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.349

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.330

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.179

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.404

UVUV-irradiationDNAdamaging

-1.836

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.101

Antimycin12.5-50 ug/mL Antimycin A?

-0.341

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.148

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.380

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.537

PA8240.2-2 ug/mL PA-824?

1.499

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.029

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.678

Verapamil50 uM Verapamil?

-0.445

mercaptoethanol2 mM 2-Mercaptoethanol?

0.002

methoxatin10-20 ug/mL Methoxatin?